NanoString Technologies to Present at J.P. Morgan 34th Annual Healthcare Conference
23 déc. 2015 16h04 HE
|
NanoString Technologies, Inc.
SEATTLE, Dec. 23, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today...
NanoString Technologies Announces Eleven Prosigna/PAM50 Presentations at the 2015 CTRC-AACR San Antonio Breast Cancer Symposium
07 déc. 2015 08h00 HE
|
NanoString Technologies, Inc.
SEATTLE, Dec. 7, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Technologies to Present at Canaccord Genuity Medical Technology and Diagnostics Forum
05 nov. 2015 16h03 HE
|
NanoString Technologies, Inc.
SEATTLE, Nov. 5, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Technologies Expands 3D Biology Portfolio With the Commercial Launch of Seven New nCounter PanCancer Profiles to Deeply Probe Cancer Biology
05 nov. 2015 08h30 HE
|
NanoString Technologies, Inc.
SEATTLE, Nov. 5, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Technologies Releases Financial Results for Third Quarter of 2015
02 nov. 2015 16h01 HE
|
NanoString Technologies, Inc.
Record Revenue of $15.7 Million Driven by Strong Consumables Demand
Expanded Solutions in Precision Oncology, including nCounter SPRINT and 3D Biology, Strengthen Company's Position at Center of...
NanoString Technologies to Release Third Quarter 2015 Financial Results and Host Conference Call on Monday, November 2, 2015
12 oct. 2015 16h01 HE
|
NanoString Technologies, Inc.
SEATTLE, Oct. 12, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Technologies to Unveil Strategic Roadmap for Growth and Market Expansion
11 sept. 2015 07h00 HE
|
NanoString Technologies, Inc.
NEW YORK, Sept. 11, 2015 (GLOBE NEWSWIRE) -- At a meeting with analysts and investors today, members of the senior management team of NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life...
NanoString Technologies Expands Immuno-Oncology Portfolio With Commercial Launch of Innovative nCounter RNA:Protein PanCancer Immune Profiling Panel
10 sept. 2015 16h05 HE
|
NanoString Technologies, Inc.
SEATTLE, Sept. 10, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
ESMO Clinical Practice Guidelines for Breast Cancer Recommend the Use of Prosigna/PAM50 Assay for Determining Potential Benefit From Chemotherapy
09 sept. 2015 08h00 HE
|
NanoString Technologies, Inc.
SEATTLE, Sept. 9, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Technologies to Host Investor Day on September 11, 2015
27 août 2015 16h01 HE
|
NanoString Technologies, Inc.
SEATTLE, Aug. 27, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...